RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Lynn Francesconi to Female

This is a "connection" page, showing publications Lynn Francesconi has written about Female.
Connection Strength

0.224
  1. Sanders VA, Iskhakov D, Abdel-Atti D, Devany M, Neary MC, Czerwinski KR, Francesconi LC. Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides. Nucl Med Biol. 2019 Jan - Feb; 68-69:1-13.
    View in: PubMed
    Score: 0.042
  2. Deri MA, Ponnala S, Kozlowski P, Burton-Pye BP, Cicek HT, Hu C, Lewis JS, Francesconi LC. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET. Bioconjug Chem. 2015 Dec 16; 26(12):2579-91.
    View in: PubMed
    Score: 0.034
  3. Deri MA, Ponnala S, Zeglis BM, Pohl G, Dannenberg JJ, Lewis JS, Francesconi LC. Alternative chelator for 8?Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO). J Med Chem. 2014 Jun 12; 57(11):4849-60.
    View in: PubMed
    Score: 0.031
  4. Thompson S, Ballard B, Jiang Z, Revskaya E, Sisay N, Miller WH, Cutler CS, Dadachova E, Francesconi LC. 166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel. Nucl Med Biol. 2014 Mar; 41(3):276-81.
    View in: PubMed
    Score: 0.030
  5. Ballard B, Jiang Z, Soll CE, Revskaya E, Cutler CS, Dadachova E, Francesconi LC. In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma. Cancer Biother Radiopharm. 2011 Oct; 26(5):547-56.
    View in: PubMed
    Score: 0.026
  6. Cyr JE, Pearson DA, Nelson CA, Lyons BA, Zheng Y, Bartis J, He J, Cantorias MV, Howell RC, Francesconi LC. Isolation, characterization, and biological evaluation of syn and anti diastereomers of [(99m)Tc]technetium depreotide: a somatostatin receptor binding tumor imaging agent. J Med Chem. 2007 Sep 06; 50(18):4295-303.
    View in: PubMed
    Score: 0.019
  7. Cantorias MV, Howell RC, Todaro L, Cyr JE, Berndorff D, Rogers RD, Francesconi LC. MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals. Inorg Chem. 2007 Sep 03; 46(18):7326-40.
    View in: PubMed
    Score: 0.019
  8. Yazdani A, Bilton H, Vito A, Genady AR, Rathmann SM, Ahmad Z, Janzen N, Czorny S, Zeglis BM, Francesconi LC, Valliant JF. A Bone-Seeking trans-Cyclooctene for Pretargeting and Bioorthogonal Chemistry: A Proof of Concept Study Using 99mTc- and 177Lu-Labeled Tetrazines. J Med Chem. 2016 Oct 27; 59(20):9381-9389.
    View in: PubMed
    Score: 0.009
  9. Cristaudo A, Francesconi L, Ambrifi M, Frasca M, Cavallotti C, Sperduti E. Efficacy of an emollient dermoprotective cream in the treatment of elderly skin affected by xerosis. G Ital Dermatol Venereol. 2015 Jun; 150(3):297-302.
    View in: PubMed
    Score: 0.008
  10. Acetoso M, Francesconi L. [Evaluation of immune status in rubella infection in the pregnant population of the U.S.L. 3 of Pesaro 1981-1985]. Quad Sclavo Diagn. 1986 Sep; 22(3):283-90.
    View in: PubMed
    Score: 0.005
  11. Abate L, Croci F, Francesconi L, Bayeli PF. [A retrospective clinico-endoscopic study of colorectal cancer. Personal case histories]. Minerva Med. 1989 Mar; 80(3):249-53.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support